Antirheumatic AgentsArthritis, RheumatoidSulfasalazineHydroxychloroquineAuranofinOrganogold CompoundsMethotrexateIsoxazolesGold Sodium ThiomalateDrug Therapy, CombinationRheumatologyPenicillamineSeverity of Illness IndexArthrographyJointsRheumatoid FactorArthritis, PsoriaticThiomalatesFoot JointsAnti-Inflammatory Agents, Non-SteroidalReceptors, Tumor Necrosis FactorTreatment OutcomeHand JointsRheumatic DiseasesTripterygiumTumor Necrosis Factor-alphaArthritisSynovitisAntibodies, Monoclonal, HumanizedUnited States Agency for Healthcare Research and QualityGlucocorticoidsAntibodies, MonoclonalSynovial MembranePrednisoloneBlood SedimentationAnti-Inflammatory AgentsSpondylitis, AnkylosingImmunoglobulin GBiological ProductsArthritis, JuvenileDisease ProgressionProduct Surveillance, PostmarketingOpportunistic InfectionsPeptides, CyclicInterleukin 1 Receptor Antagonist ProteinDouble-Blind MethodWrist JointDrug Administration ScheduleTreatment FailureFinger JointRemission InductionImmunosuppressive AgentsEarly DiagnosisCohort StudiesInjections, SubcutaneousFollow-Up StudiesImmunoconjugatesTime FactorsClinical Trials as TopicGoldAdrenal Cortex HormonesProspective StudiesImmunologic FactorsDose-Response Relationship, DrugAutoantibodiesHealth StatusDisability EvaluationEpidemiologic MethodsOsteoarthritisC-Reactive ProteinStatistics, NonparametricPlacebosPrednisonePhysician's Practice Patterns